Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Digital Unicesumar |
Texto Completo: | http://rdu.unicesumar.edu.br/handle/123456789/7576 |
Resumo: | The trypanosoma cruzi is a protozoan that causes a serious infeccion in the vertebrate host, being capable of causing irreversible damages, mainly in the muscle cells, also known as trypanosomiasis disease or Chagas Disease. The commercially avaible drug medication wich fights this parasite is not completly eficiente and causes undesireble and irreversible damages, making it necessary to search for other fields of medicine, in terms of medication, to combat this disease. Therefore, research with homeopathic medicines has being promising in the fight against the parasite, especially the amastigote forms, which are more difficult to be exterminated. Biotherapics are the homeopathic ones that have been more successful in relation to T. cruzi infection, since these drugs have their active principle removed from the parasite itself, its toxins, part of its members, performing a therapy known as isotherapy - cure by the same. The work was carried out with analysis of 100 histological slides, in 'zigzag', 'listing cells, infected or not by amastigotes, as well as cells of innate or acquired immunity. The work had the existence of three groups: control, treated continuously and treated only at the beginning of the infection. The results indicates that the 200dH biotherapic acts by coercing the immune system to fight T. cruzi in contaminated guinea pigs, promoting a cellular and humoral imune response more efficient than the physiological one. It is believed that this medicine works by stimulating the defense cells, which will respond in an antigenspecific manner, favoring the fight against amastigotes. This process is probably initiated by the stimulation of the macrophage, which in turn, according to the remains found, initiates an inflammatory cascade, with predominance of the Th1 pathway, promoting the production of IL-4e IL-5 and γ interferon, helping to combat amastigotes. With this result, the cure for homeopathy, of an infectious disease, shows promise, being an innovative and important field of medicine, requiring further investigation. |
id |
UNICESU -1_1f4d5b03297c7a86deff5c28ef10446a |
---|---|
oai_identifier_str |
oai:rdu.unicesumar.edu.br:123456789/7576 |
network_acronym_str |
UNICESU -1 |
network_name_str |
Repositório Digital Unicesumar |
repository_id_str |
|
spelling |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruziBioterápicosDoença de ChagasHomeopatiaT. cruziCNPQ::CIENCIAS DA SAUDE::MEDICINAThe trypanosoma cruzi is a protozoan that causes a serious infeccion in the vertebrate host, being capable of causing irreversible damages, mainly in the muscle cells, also known as trypanosomiasis disease or Chagas Disease. The commercially avaible drug medication wich fights this parasite is not completly eficiente and causes undesireble and irreversible damages, making it necessary to search for other fields of medicine, in terms of medication, to combat this disease. Therefore, research with homeopathic medicines has being promising in the fight against the parasite, especially the amastigote forms, which are more difficult to be exterminated. Biotherapics are the homeopathic ones that have been more successful in relation to T. cruzi infection, since these drugs have their active principle removed from the parasite itself, its toxins, part of its members, performing a therapy known as isotherapy - cure by the same. The work was carried out with analysis of 100 histological slides, in 'zigzag', 'listing cells, infected or not by amastigotes, as well as cells of innate or acquired immunity. The work had the existence of three groups: control, treated continuously and treated only at the beginning of the infection. The results indicates that the 200dH biotherapic acts by coercing the immune system to fight T. cruzi in contaminated guinea pigs, promoting a cellular and humoral imune response more efficient than the physiological one. It is believed that this medicine works by stimulating the defense cells, which will respond in an antigenspecific manner, favoring the fight against amastigotes. This process is probably initiated by the stimulation of the macrophage, which in turn, according to the remains found, initiates an inflammatory cascade, with predominance of the Th1 pathway, promoting the production of IL-4e IL-5 and γ interferon, helping to combat amastigotes. With this result, the cure for homeopathy, of an infectious disease, shows promise, being an innovative and important field of medicine, requiring further investigation.O Tripanosoma cruzi é um protozoário que instaura uma infecção grave em seu hospedeiro vertebrado, podendo causar danos irreversíveis, principalmente em suas células musculares, conhecida como a doença tripanossomíase ou Doença de Chagas. A medicação disponível no mercado, que combate esse parasito, não é completamente eficiente e produz danos indesejáveis e irreversíveis, fazendo-se necessário a busca por outros campos da medicina, em termos de medicação, para combater essa doença. Nesse sentido, pesquisas com medicamentos homeopáticos têm se revelado promissoras no combate ao parasito, sobretudo as formas amastigotas, que são mais difíceis de serem exterminadas. Os bioterápicos são os homeopáticos que obtiveram maior sucesso em relação à infecção por T. cruzi, uma vez que esses medicamentos possuem seu princípio ativo retirado do próprio parasito, suas toxinas, parte de membras, realizando uma terapia conhecida como isoterapia – cura pelo igual. O trabalho foi realizado com analise de 100 lâminas histológicas, em ‘ziguezague’’, cotando células, infectadas ou não pelas amastigotas, bem como células da imunidade inata ou adquirida. O trabalho contou com a existência de três grupos: controle, tratado continuamente e tratado apenas no início da infecção. Resultados encontrados indicam que o bioterápico 200dH atua coagindo o sistema imune a combater o T. cruzi em cobaias contaminadas, fomentando uma resposta imune celular e humoral mais eficiente do que a fisiológica. Acredita-se que esse medicamento atue estimulando as células de defesa, que passarão a responder de forma antígeno-específico, favorecendo o combate de amastigotas. Esse processo, provavelmente, é iniciado pela estimulação do macrófago, que por sua vez, de acordo com os resultados encontrados, inicia uma cascata inflamatória, com predominância da via Th1, fomentando a produção de IL4, IL-10 e interferon γ, auxiliando no combate as amastigotas. Com esse resultado, a cura pela homeopatia, de uma doença infecciosa, se demonstra promissora, sendo um campo inovador e importante da medicina, necessitando de mais investigação.UNIVERSIDADE CESUMARBrasilUNICESUMAROLIVEIRA, Simone Martins deOLIVEIRA, Simone Martins deSILVA, Maria Fernanda Piffer Tomasi Baldez daBARROS, Eduarda Pereira de2021-02-16T14:46:46Z2021-02-162021-02-16T14:46:46Z2021-02-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfBARROS, Eduarda Pereira de. Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi. 16f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.Presencialhttp://rdu.unicesumar.edu.br/handle/123456789/7576porinfo:eu-repo/semantics/openAccessreponame:Repositório Digital Unicesumarinstname:Centro Universitário de Maringá (UNICESUMAR)instacron:UniCesumar2021-02-17T06:02:10ZRepositório InstitucionalPRI |
dc.title.none.fl_str_mv |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
title |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
spellingShingle |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi BARROS, Eduarda Pereira de Bioterápicos Doença de Chagas Homeopatia T. cruzi CNPQ::CIENCIAS DA SAUDE::MEDICINA |
title_short |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
title_full |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
title_fullStr |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
title_full_unstemmed |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
title_sort |
Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi |
author |
BARROS, Eduarda Pereira de |
author_facet |
BARROS, Eduarda Pereira de |
author_role |
author |
dc.contributor.none.fl_str_mv |
OLIVEIRA, Simone Martins de OLIVEIRA, Simone Martins de SILVA, Maria Fernanda Piffer Tomasi Baldez da |
dc.contributor.author.fl_str_mv |
BARROS, Eduarda Pereira de |
dc.subject.por.fl_str_mv |
Bioterápicos Doença de Chagas Homeopatia T. cruzi CNPQ::CIENCIAS DA SAUDE::MEDICINA |
topic |
Bioterápicos Doença de Chagas Homeopatia T. cruzi CNPQ::CIENCIAS DA SAUDE::MEDICINA |
description |
The trypanosoma cruzi is a protozoan that causes a serious infeccion in the vertebrate host, being capable of causing irreversible damages, mainly in the muscle cells, also known as trypanosomiasis disease or Chagas Disease. The commercially avaible drug medication wich fights this parasite is not completly eficiente and causes undesireble and irreversible damages, making it necessary to search for other fields of medicine, in terms of medication, to combat this disease. Therefore, research with homeopathic medicines has being promising in the fight against the parasite, especially the amastigote forms, which are more difficult to be exterminated. Biotherapics are the homeopathic ones that have been more successful in relation to T. cruzi infection, since these drugs have their active principle removed from the parasite itself, its toxins, part of its members, performing a therapy known as isotherapy - cure by the same. The work was carried out with analysis of 100 histological slides, in 'zigzag', 'listing cells, infected or not by amastigotes, as well as cells of innate or acquired immunity. The work had the existence of three groups: control, treated continuously and treated only at the beginning of the infection. The results indicates that the 200dH biotherapic acts by coercing the immune system to fight T. cruzi in contaminated guinea pigs, promoting a cellular and humoral imune response more efficient than the physiological one. It is believed that this medicine works by stimulating the defense cells, which will respond in an antigenspecific manner, favoring the fight against amastigotes. This process is probably initiated by the stimulation of the macrophage, which in turn, according to the remains found, initiates an inflammatory cascade, with predominance of the Th1 pathway, promoting the production of IL-4e IL-5 and γ interferon, helping to combat amastigotes. With this result, the cure for homeopathy, of an infectious disease, shows promise, being an innovative and important field of medicine, requiring further investigation. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02-16T14:46:46Z 2021-02-16 2021-02-16T14:46:46Z 2021-02-16 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
BARROS, Eduarda Pereira de. Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi. 16f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020. Presencial http://rdu.unicesumar.edu.br/handle/123456789/7576 |
identifier_str_mv |
BARROS, Eduarda Pereira de. Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi. 16f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020. Presencial |
url |
http://rdu.unicesumar.edu.br/handle/123456789/7576 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
UNIVERSIDADE CESUMAR Brasil UNICESUMAR |
publisher.none.fl_str_mv |
UNIVERSIDADE CESUMAR Brasil UNICESUMAR |
dc.source.none.fl_str_mv |
reponame:Repositório Digital Unicesumar instname:Centro Universitário de Maringá (UNICESUMAR) instacron:UniCesumar |
instname_str |
Centro Universitário de Maringá (UNICESUMAR) |
instacron_str |
UniCesumar |
institution |
UniCesumar |
reponame_str |
Repositório Digital Unicesumar |
collection |
Repositório Digital Unicesumar |
repository.name.fl_str_mv |
|
repository.mail.fl_str_mv |
|
_version_ |
1747771966397349888 |